login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
FDA Gives Approval for Weekly Shot of Bydureon in Treatment of Type 2 Diabetes
The drug, an injection, is actually a long-acting form of Byetta. This shot can be used in combination with diet and exercise to improve blood sugar control among people with Type 2 diabetes.
Bydureon, is manufactured by Alkermes PLC and Amylin Pharmaceuticals Inc. Initially the FDA had not approved this drug as there were concerns that it might increase the risk of heart problems. As part of the new approval, the FDA has asked the organization to conduct a study to gauge whether the drug actually elevates risk of heart disease.
John Buse, MD, PhD, professor of medicine, director of the Diabetes Care Center, and chief of the division of endocrinology at the University Of North Carolina School Of Medicine in Chapel Hill said, With Bydureon, U.S. physicians and patients can now choose a therapy that offers continuous blood sugar control in just one dose per week.
Source-Medindia
|
|
More News on: Otitis Media
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
 | Quiz on Diabetes Are you at risk for diabetes? To find out check out our health quiz. 
|
- News Quick Links
 |
Diabetes
Complete Medindia Resources
|
| News Categories: |
| » | Mystery of 'Disappearing' Tweets Solved |
| » | 'Slut Walks' Attract Thousands in Brazil |
| » | Enthusiasm for Tattoos High Among Women |
| » | Individuals' Brains 'Tick Together' If They Have Strong Emotions |
| » | Keeping Emotions in Check and Being Resilient Helps to Remain Satisfied With Life |
| More Life Style News | |
|
